Austin, TX 的 過重 臨床試驗
18 項針對 過重 的研究正在 Austin（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
招募中2 期
- Elligo Clinical Research Center /ID# 282166, Austin
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
招募中3 期
- Texas Diabetes & Endocrinology, Austin
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- IMA Clinical Research Austin, Austin
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
招募中3 期
- Dell Children's Medical Center - PIN, Austin
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- IMA Clinical Research Austin, Austin
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
招募中3 期
- FutureSearch Trials of Neurology, Austin
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
招募中3 期
- Austin Heart, Austin
- Velocity Clinical Research - Austin, Austin
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
招募中2 期
- IMA Clinical Research Austin, Austin
Semaglutide for Post-Smoking Cessation Weight Management
招募中2 期歡迎健康志工
- The University of Texas at Austin, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Austin
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期歡迎健康志工
- ACCOMPLISH-2 Research Site, Austin
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
招募中2 期
- IMA Clinical Research Austin, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
招募中3 期
- Elligo Clinical Research Center, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
招募中3 期
- Elligo Clinical Research Center, Austin
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Austin
- ACCOMPLISH-1 Research Site, Austin
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
招募中1 期
- Elligo Clin Res Centre, Austin
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
招募中1 期
- Corxel Investigational Site, Austin
其他城市的 過重 試驗
- San Antonio, TX34 項研究
- Houston, TX33 項研究
- Chicago, IL28 項研究
- Orlando, FL27 項研究
- Las Vegas, NV23 項研究
- Miami, FL23 項研究
- Atlanta, GA20 項研究
- Dallas, TX20 項研究
- New York City, NY19 項研究
- Jacksonville, FL19 項研究
- Washington, DC19 項研究
- Baltimore, MD17 項研究
Austin 的其他研究
- 非小細胞肺癌30 項研究
- 癌症（所有類型）20 項研究
- 肥胖症20 項研究
- 轉移性癌症19 項研究
- 大腸直腸癌19 項研究
- 心臟衰竭18 項研究
- 乳癌18 項研究
- 卵巢癌17 項研究
- 子宮內膜癌15 項研究
- 前列腺癌15 項研究
- 憂鬱症14 項研究
- 三陰性乳癌13 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。